Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from CEA high and CEA low cells in colorectal cancer

ABSTRACT: We used microarrays to detailed global expression of colorectal cancer cells that expressed high or low levels of carcinoembryonic antigen.

ORGANISM(S): Homo sapiens

PROVIDER: GSE72398 | GEO | 2015/08/27

SECONDARY ACCESSION(S): PRJNA293947

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data from CEA high and CEA low cells in colorectal cancer

Project description:We used microarrays to detailed global expression of colorectal cancer cells that expressed high or low levels of carcinoembryonic antigen. CEA high and CEA low cells were purified from LoVo and xenograft tumor derived from colorectal cancer patient (xhCRC) and were used for RNA extraction.

2015-08-27 | E-GEOD-72398 | biostudies-arrayexpress

Clinical Assay for the Early Detection of Colorectal Cancer Using Mass Spectrometric Wheat Germ Agglutinin Multiple Reaction Monitoring

Project description:Colorectal cancer (CRC) is currently the third leading cause of cancer related mortality in the world. U.S. Food and Drug Administration-approval circulating tumor markers, including carcinoembryonic antigen, carbohydrate antigen (CA) 19-9 and CA125, were used as prognostic biomarker of CRC that attributed to low sensitivity in diagnosis of CRC. Therefore, our purpose is to develop a novel strategy for novel clinical biomarker for early CRC diagnosis. We used mass spectrometry (MS) methods such as nanoLC-MS/MS, targeted LC-MS/MS, and stable iso-tope-labeled multiple reaction monitoring (MRM) MS coupled to machine learning algorithms and logistic regression to analyze plasma samples from patients with early-stage CRC, late-stage CRC, and healthy controls (HCs).

2021-07-29 | PXD024997 | Pride

microRNA expression profiling among WTX low human colorectal cancer tissues and matched adjacent WTX high normal colorectal mucosa

Project description:Comparing to matched normal mucosa, WTX was lost in most of human colorectal cancers (Zhang et al., 2016). We analyzed the microRNA expression profiling among WTX low human colorectal cancer tissues and matched adjacent WTX high normal colorectal mucosa. The aimed to identify the unique signature of miRNAs which related to WTX loss in human colorectal cancers.

2017-02-15 | GSE94881 | GEO

Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer

Project description:This is a comparative study. This study is to compare the diagnostic sensitivity between circulating tumor DNA methylation and carcinoembryonic antigen in detecting colorectal cancer. There are two steps in this study. Firstly, the diagnostic model is established based on tumor-specific plasma circulating tumor DNA methylation markers. Secondly, the sensitivity, specificity and accuracy of plasma circulating tumor DNA methylation are compared with that of carcinoembryonic antigen in detecting colorectal cancer.

| 2749747 | ecrin-mdr-crc

Optimized high-order low-dose drug mixtures boost selectivity and efficacy of colorectal carcinoma treatment

Project description:Colorectal carcinoma is currently treated with a combination of chemotherapeutics, often supplemented with targeted drugs. Despite recent improvements, an urgent need exists for improved efficacy, especially at late stage disease, and minimized side effects. Therefore, we employed the recently developed mathematical approach of the phenotypically-driven therapeutically guided multidrug optimization (TGMO) technology, to identify individualized optimal drug combinations (ODCs). Using this technology we obtained low dose synergistic and selective ODCs for a panel of human colorectal carcinoma cells, active in 3-dimensional heterotypic co-culture models. RNA sequencing and phosphoproteomics analyses showed that the mechanisms of action of these ODCs converge towards MAP kinase signaling and cell cycle inhibition despite differential cell mutation status, transcript expression levels and protein kinase phosphorylation state. Two cell-specific ODCs were subsequently translated to two in vivo models. Interestingly, the ODCs reduced tumor growth by approximately 80% and significantly outperformed the standard chemotherapy (FOLFOX). Complete lack of toxicity was observed for the ODCs, while still significant after FOLFOX therapy. Pharmacokinetics demonstrated that the drug combinations showed significantly enhanced bioavailability. Finally, the high-order ODCs were also active in freshly isolated cells from patient tumor tissues. Taken together, we show that the TGMO technology efficiently guides towards selective and potent low-dose drug combinations, optimized regardless of tumor mutation status and outperforming conventional chemotherapy.

2020-09-01 | GSE142340 | GEO

Genome-Wide DNA Methylation Profiles of Low- and High-Grade Adenoma Reveals Potential Biomarkers for Early Diagnosis of Colorectal Carcinoma

Project description:Abnormal DNA methylation is a hallmark of human cancers and may be a promising biomarker for early diagnosis of human cancers1. However, the majority of DNA methylation biomarkers that have been identified are based on the hypothesis that early differential methylation regions (DMRs) are maintained throughout carcinogenesis and could be detected at all stages of cancer. In this study, we identified potential early biomarkers of colorectal cancer (CRC) development by genome-wide DNA methylation assay (Illumina infinium450, 450K) to normal (N=20) and pre-colorectal cancer samples including 18 low-grade adenoma (LGA) and 22 high-grade adenoma (HGA).

2020-04-23 | GSE139404 | GEO

Transcription profiling by array of human colorectal carcinoma patients expressing either high or low levels of human guanylate binding protein-1 (GBP-1) to identify coregulated genes

Project description:The gene expression profile of 24 human colorectal carcinoma patients either expressing high (n=12) or low (n=12) levels of human guanylate binding protein-1 (GBP-1) were compared in order to identify coregulated genes.

2008-07-31 | E-MEXP-833 | biostudies-arrayexpress

Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.

Project description:We performed comprehensive genome-scale DNA methylation profiling by Illumina Infinium HumanMethylation27 of 18 DNA pools that represent 84 colorectal cancer (CRC) samples divided according to their high-, intermediate-, and low-methylation epigenotypes (HME, IME, and LME, respectively) and 3 pools representing 70 normal-adjacent colonic tissues.

2013-03-08 | GSE37740 | GEO

Mus musculus

Project description:Decorin and EphA2 mediate Carcinoembryonic Antigen Cell Adhesion Molecule 1-L inhibition of colorectal cancer metastasis

| PRJNA296370 | ENA

Low/high crop season

Project description:Low/high crop season Metagenome

| PRJNA688798 | ENA